Advertisement

O.C. EARNINGS

Share via

Cortex Pharmaceuticals Inc.: The Irvine developer of treatments for neurological and other psychiatric disorders posted a net loss of $1.17 million, or 12 cents a share, for the fourth quarter, ended June 30, compared with a net loss of $1.28 million, or 25 cents a share, for the same period a year earlier. The company reported no revenue. For the year, Cortex lost $5.3 million, or 55 cents a share, compared with a loss of $4.9 million, or 83 cents a share on a lower number of shares outstanding, the previous year. Revenue totaled $130,000, compared with no revenue the previous year.

Advertisement